For research use only. Not for therapeutic Use.
Mizoribine(Cat No.:A000603)is an immunosuppressive agent derived from Eupenicillium brefeldianum, primarily used to inhibit purine synthesis. It selectively targets inosine monophosphate dehydrogenase (IMPDH) and guanosine monophosphate synthetase, enzymes essential for the de novo synthesis of guanine nucleotides. By suppressing lymphocyte proliferation, Mizoribine is effective in managing autoimmune diseases and preventing organ transplant rejection. It has a favorable safety profile compared to other immunosuppressants, reducing risks of severe infections. Mizoribine continues to be studied for its potential in treating inflammatory and immune-mediated disorders.
CAS Number | 50924-49-7 |
Synonyms | 50924-49-7; Bredinin; Bredinine; Mizoribinum; Mizoribina |
Molecular Formula | C9H13N3O6 |
Purity | ≥95% |
Target | HCV |
Solubility | Limited solubility |
Storage | -20°C |
IUPAC Name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide |
InChI | InChI=1S/C9H13N3O6/c10-7(16)4-8(17)12(2-11-4)9-6(15)5(14)3(1-13)18-9/h2-3,5-6,9,13-15,17H,1H2,(H2,10,16)/t3-,5-,6-,9-/m1/s1 |
InChIKey | HZQDCMWJEBCWBR-UUOKFMHZSA-N |
SMILES | C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N |
Reference | <br />1: Kawamura T, Usui J, Nagai K, Sakai K, Ebihara I, Yamagata K. Maintenance 2: Nishioka T, Yoshimura N, Ushigome H, Watarai Y, Nishimura K, Akioka K, <br> <br> <br> 6: Harada S, Nakamura T, Ushigome H, Akutsu N, Akioka K, Nakatani T, Yoshimura N. <br> 8: Mima A. Efficacy of mizoribine and prednisolone combination therapy in adult <br> 10: Sakurai K, Kubo K, Kanda H, Fujio K, Yamamoto K. Efficacy of combination |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |